Quick Answer
Corbus Pharmaceuticals Holdings, Inc. reported Cash And Cash Equivalents At Carrying Value of $28.49 million for the year ending 2025.
- Corbus Pharmaceuticals Holdings, Inc. showed an increase of +65.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Corbus Pharmaceuticals Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), Corbus Pharmaceuticals Holdings, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 5,152.1%.
- Historical annual values: Fiscal year 2025: $28.49 million | Fiscal year 2024: $17.20 million | Fiscal year 2023: $13.72 million | Fiscal year 2022: $17.00 million | Fiscal year 2021: $25.01 million | Fiscal year 2020: $85.43 million | Fiscal year 2019: $31.75 million | Fiscal year 2018: $41.75 million | Fiscal year 2017: $62.54 million | Fiscal year 2016: $14.99 million | Fiscal year 2015: $12.34 million | Fiscal year 2014: $6.26 million | Fiscal year 2013: $303.0 thousand | Fiscal year 2012: $542.5 thousand.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: